logo

Investing In The Biotech Sector: Here’s An Easy Way To Profit From Biotech Stocks
By: Investment U   Wednesday, November 11, 2009 10:44 AM

Vote for next session
The next market session will close:

by Marc Lichtenfeld, Healthcare Expert

Wednesday, November 11, 2009: Issue #1135

Investing in the biotech sector can be risky – no doubt about that.

But you know what? There are a lot of ways to make money from biotech stocks, too. If you know what to look for, that is.

Two obvious examples include:

  • Picking the company behind the next breakthrough drug for cancer or Alzheimer's.
  • Digging out companies that are likely takeover targets (something my colleague Louis Basenese does expertly in his Takeover Trader service), or landing lucrative drug partnership deals, which send the stocks higher.

But there's another excellent way that shorter-term investors can grab gains and profit from biotech sector…

Follow the Biotech Sector Conference Buzz

Throughout the year, the biotech sector holds many key conferences where biotech companies make important presentations. If you keep your ear to the ground, you can adopt a proven investment strategy: profiting from the news before it breaks.

Now, there's obviously no guarantee that the stocks in question will rise, or even that the data they present will be positive. But very often, their stocks rise in the days or weeks before these conferences, in anticipation of good news.

Here are a few important conferences to keep an eye on – and some companies that could enjoy some positive press from them…

Three Conferences & Five Biotech Stocks for Your Watch List

On November 15, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference (surely a leading candidate for the Wordiest Conference Of the Year Award) starts in Boston.


Next Page >>123

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Investment U



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia